Ionis Pharmaceuticals (NASDAQ:IONS) announced that European regulators recommended expanding TRYNGOLZA's indication to adults with severe hypertriglyceridemia and fasting triglycerides of at least 880 mg/dL.
GE Aerospace (NYSE:GE), through its CFM International joint venture with Safran, signed an agreement in principle covering more than 300 LEAP-1B engines for Turkish Airlines' Boeing 737 MAX fleet.
Truist Financial (NYSE:TFC) reported third-quarter 2026 adjusted earnings of $1.16 per share, exceeding Wall Street's $1.14 estimate, while revenue fell short of expectations.
Omeros (NASDAQ:OMER) said Europe's drug review committee maintained its negative opinion on narsoplimab for TA-TMA after re-examination, despite the treatment receiving U.S. approval in December 2025.
Citizens Financial Group (NYSE:CFG) reported third-quarter 2026 net income of $636 million, up 29% year over year, while diluted earnings per share increased 34% to $1.41.
Vertical Aerospace (NYSE:EVTL) signed two long-term supplier agreements with ANH Structure and Northrop Grumman LITEF to supply seating and navigation systems for its Valo electric aircraft.
Regions Financial (NYSE:RF) reported third-quarter 2026 earnings available to common shareholders of $611 million, with diluted earnings of $0.71 per share, up 16% year over year.
JinkoSolar (NYSE:JKS) announced that its 54.32%-owned subsidiary Jiangxi Jinko estimates a shareholder-attributable net loss of RMB2.97633 billion–RMB3.57633 billion for the first nine months of 2026.
DataMeds AI (NASDAQ:MEDS) outlined plans on October 16, 2026, for its three Corexa Health divisions following an FDA proposal that could ease compounding restrictions on six peptides.
Microsoft (NASDAQ:MSFT) faces potential UK regulatory restrictions after the Competition and Markets Authority proposed strategic market status for its business software ecosystem on October 16, 2026.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
